Genetic Variation of a −176g>c Interleukin-6 Correlated with White Blood Cells Count in Obesity of Indonesia
DOI:
https://doi.org/10.3889/oamjms.2021.6149Keywords:
Obesity, Platelets, Interleukin-6 Genes, Leukocytes, LymphocytesAbstract
BACKGROUND: Obesity is a risk factor for cardiovascular disease. Obesity can trigger inflammation by increasing the synthesis of interleukin-6 (IL-6) which leads to leukocyte recruitment, differentiation of B lymphocytes, activating T lymphocyte cells, and triggering hematopoiesis. Variations in the IL-6 promoter gene are known to affect transcription rates. The previous studies have still found different results regarding the relationship between these gene variations and blood cell numbers.
AIM: This study aimed to determine the influence of IL-6 gene variation with white blood cells counts in obese people of Indonesia.
METHODS: A total of 148 people participated in this cross-sectional study. The number of obese people was 80 subjects and there were 68 non-obese people as controls. Obesity was determined based on the criteria of Asians.
RESULTS: Genotype CC was not found in this study, while the GC genotype was found only in the obese group. The GG genotype in obese group had waist circumference, diastolic blood pressure, and higher lymphocyte rates significantly higher than the non-obese group (p < 0.05).
CONCLUSIONS: Variation of −174G>C IL-6 gene is associated with high white blood cell counts, especially lymphocytes number in obese people in Indonesia.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Hruby A, Hu FB. The epidemiology of obesity: A big picture. Pharmacoeconomics. 2015;33(7):673-89. PMid:25471927 DOI: https://doi.org/10.1007/s40273-014-0243-x
World Health Organization. Obesity and Overweight; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. [Last accessed on 2021 Mar 23].
Redinger RN. The pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol (N Y). 2007;3(11):856-63. PMid:21960798
Hoene M, Weigert C. The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev. 2008;9(1):20-9. PMid:17956545
Tanaka T, Narazaki M, Kishimoto T. IL-6 in Inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. https://doi.org/10.1101/cshperspect.a016295 PMid:25190079 DOI: https://doi.org/10.1101/cshperspect.a016295
Parham P. The Immune System. New York: Garland Science; 2015. DOI: https://doi.org/10.1201/9781317511571
Arman M, Payne H, Ponomaryov T, dan Brill A. Role of platelets in inflammation. In: The Non-Thrombotic Role of Platelets in Health and Disease. 2015. p. 37-40. https://doi.org/10.5772/60536 DOI: https://doi.org/10.5772/60536
Nadeem A, Naveed AK, Hussain MM, Aslam M, Siddiqui A, Saeed SA. Variations in association of interleukin 6-G174C single nucleotide polymorphism with Type 2 diabetes mellitus-a review. Int J Diabetes Dev Ctries. 2013;33(4):186-91. https://doi.org/10.1007/s13410-013-0147-x
Byrne CE, Fitzgerald A, Cannon CP, Fitzgerald DJ, Shields DC. Elevated white cell count in acute coronary syndromes: Relationship to variants in inflammatory and thrombotic genes. BMC Med Genet. 2004;5:13. https://doi.org/10.1186/1471-2350-5-13 PMid:15171792 DOI: https://doi.org/10.1186/1471-2350-5-13
Danielsson P, Truedsson L, Eriksson KF, Norgren L. Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus. Vasc Med. 2005;10(3):191-8. https://doi.org/10.1191/1358863x05vm617oa PMid:16235772 DOI: https://doi.org/10.1191/1358863x05vm617oa
Puspasari A, Maharani C, Mus R, Setyawati I, Hastuti P. Higher circulating white blood cell and lymphocyte counts in obese metabolic syndrome patients: A preliminary population-based study in Yogyakarta, Indonesia. Malays J Med Health Sci. 2020;16(4):34-9.
Kurniati N. Obesity and central obesity. Med J Indones. 2018;27(2):114-20.
Hastuti P, Martantiningtyas DC, Karita D, Tasmini T, Sadewa AH. Association of-174 G>C interleukin-6 gene polymorphism with interleukin-6 and C-reactive protein levels and obesity: A case-control study among people/residents of western Indonesia. Med J Malaysia. 2019;74(5):400-4. PMid:31649216
Shehab MJ, Abdul-Hassan IA. The association of interleukin-6 gene polymorphism at -174G˃C SNP in Iraqi patients with Type 2 diabetes mellitus. Elixir Int J. 2015;88:36372-6.
World Health Organization Western Pacific Region. The Asia-Pacific Perspective: Redefining Obesity and its Treatment; 2000. Available from: https://www.apps.who.int/iris/bitstream/handle/10665/206936/0957708211_eng.pdf. [Last accessed on 2021 Mar 25].
Gan GG, Subramaniam R, Nadarajan VS. Ethnic variation in interleukin-6-174 (G/C) polymorphism in the Malaysian population. Balkan J Med Genet. 2013;16(2):53-8. https://doi.org/10.2478/bjmg-2013-0032 DOI: https://doi.org/10.2478/bjmg-2013-0032
Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: An endocrine organ. Arch Med Sci. 2013;9(2):191-200. PMid:23671428 DOI: https://doi.org/10.5114/aoms.2013.33181
Nadeem A, Naveed A, Hussain MM, Aslam M, Siddqul A, Saeed SA. Variations in association of interleukin 6-G174C single nucleotide polymorphism with Type 2 diabetes mellitus: A review. Int J Diabetes Dev Ctries. 2013;33(4):186-91. https://doi.org/10.1007/s13410-013-0147-x DOI: https://doi.org/10.1007/s13410-013-0147-x
Ma H, Sun G, Wang W, Zhou Y, Liu D, Tong Y, et al. Association between interleukin-6-572 C>G and -174 G>C polymorphisms and hypertension. Medicine. 2016;95(2):1-15. DOI: https://doi.org/10.1097/MD.0000000000002416
Fernandez-Real J, Vendrell J, Richart C, Gutierrez C, Ricart W. Platelet count and Interleukin 6 gene polymorphism in healthy subjects. BMC Med Genet. 2001;2:6. https://doi.org/10.1186/1471-2350-2-6 PMid:11397324 DOI: https://doi.org/10.1186/1471-2350-2-6
Kurniati N. Obesity and central obesity. Med J Indones. 2018;27(2):69-70. DOI: https://doi.org/10.13181/mji.v27i2.3014
Popko K, Gorska E, Demkow U. Influence of Interleukin-6 and G174c polymorphism in Il-6 gene on obesity and energy balance. Eur J Med Res. 2010;15 Suppl 2:123-7. https://doi.org/10.1186/2047-783x-15-s2-123 PMid:21147639 DOI: https://doi.org/10.1186/2047-783X-15-S2-123
Tanase MD, Gosav EM, Radu S, Ouatu A, Rezus C, Ciociou M, et al. Arterial hypertension and interleukins: Potential therapeutic target or future diagnostic marker? Int J Hypertens. 2019;2019:3159283. https://doi.org/10.1155/2019/3159283 PMid:31186952 DOI: https://doi.org/10.1155/2019/3159283
Downloads
Published
How to Cite
License
Copyright (c) 2021 Dwi Eni Danarsih, Pramudji Hastuti, Agus Kristianto (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0